TCI Wealth Advisors’s AYTU BioPharma AYTU Stock Holding History

TCI Wealth Advisors’s Portfolio AYTU Stock Details AYTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	–	–	2506
2022 Q3	–	Hold	0	–	–	–	2254
2022 Q2	–	Hold	0	–	–	–	2275
2022 Q1	–	Hold	0	–	–	–	2227
2021 Q4	–	Hold	0	–	–	–	2300
2021 Q3	–	Hold	0	–	–	–	2379
2021 Q2	–	Hold	0	–	–	–	2316
2021 Q1	–	Hold	0	–	–	–	2165
2020 Q4	–	Hold	0	–	–	–	1540
2020 Q3	–	Hold	0	–	–	–	1527
2020 Q2	–	Sell	-1	Closed	-$303	–	1461
2020 Q1	$0	Buy	+1	New	+$193	﹤0.01%	1473
2019 Q4	–	Hold	0	–	–	–	1535
2019 Q3	–	Hold	0	–	–	–	1497
2019 Q2	–	Hold	0	–	–	–	1417
2019 Q1	–	Hold	0	–	–	–	1411
2018 Q4	–	Hold	0	–	–	–	1448
2018 Q3	–	Hold	0	–	–	–	1465
2018 Q2	–	Hold	0	–	–	–	1503
2018 Q1	–	Hold	0	–	–	–	1352
2017 Q4	–	Hold	0	–	–	–	1372

Other funds holding AYTU

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

ACM

Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

TCI Wealth Advisors's AYTU Position: Q4 2022 in Review

TCI Wealth Advisors held its AYTU BioPharma (AYTU) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

TCI Wealth Advisors first reported a position in AYTU in Q1 2020 and has held it in 1 quarter since. The position peaked at $0 in Q1 2020. 36 funds tracked by Wall St. Rank hold AYTU as of Q4 2022.

TCI Wealth Advisors held 0 shares of AYTU BioPharma worth $0 as of Q4 2022.
TCI Wealth Advisors left its AYTU BioPharma share count unchanged in Q4 2022.
AYTU BioPharma made up ﹤0.01% of TCI Wealth Advisors's portfolio in Q4 2022, its #2506 holding.
TCI Wealth Advisors first reported a position in AYTU BioPharma in Q1 2020 and has held it in 1 quarter since.
TCI Wealth Advisors's AYTU BioPharma position peaked at $0 in Q1 2020.
36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2022.

Based on TCI Wealth Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.